/
GFOO
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.03
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $61.0K | $41.2K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $43.2K | $21.5K | $0 | $0 | $0 | $0 | $3.8K | $3.0K |
| Gross profit | $17.8K | $19.8K | $0 | $0 | $0 | $0 | −$3.8K | −$3.0K |
| Gross margin | 29.2% | 47.9% | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$443.9K | −$1.7M | −$282.2K | −$303.5K | −$309.9K | −$363.6K | −$396.3K | −$432.3K |
| EBITDA | −$439.2K | −$1.7M | −$282.2K | −$303.3K | −$309.9K | −$311.4K | −$352.7K | −$239.9K |
| Net income | −$442.8K | −$1.7M | −$282.2K | −$303.6K | −$312.3K | −$1.4M | −$352.7K | −$627.7K |
| Net margin | -725.9% | -4081.2% | — | — | — | — | — | — |
| EPS (diluted) | -0.11 | -0.43 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.00
Price
$0.00
Implied upside
+3601%
Peer comparison
GENUFOOD EGY ENZYMES
GENUFOOD EGY ENZYMES
Held by traders on TradeandTell
No one on the platform currently holds GFOO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GFOO as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2020-07-23 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded GFOO yet.